Oral acne medication in Korea: isotretinoin to hormones

Adult acne is acne that persists past the mid-twenties or appears for the first time in adulthood, and it tends to end up somewhere on the treatment ladder that teenagers rarely reach. Oral acne medication in Korea is prescription-only and falls into three groups: isotretinoin, oral antibiotics, and hormonal treatment for adult women. Korean clinics prescribe all three at volume. The decision that actually shapes the next six months is not which clinic you walk into — it is which of the three your acne is asking for, and what each one asks of you in return.

Why does adult acne end up on oral medication?#

Adult acne moves to oral medication when topical treatment alone stops being enough, which happens more often in adults than in teenagers because adult lesions tend to sit deeper and leave marks behind. The 2024 American Academy of Dermatology guidelines of care for acne vulgaris make strong recommendations for benzoyl peroxide, topical retinoids, topical antibiotics, and oral doxycycline, and reserve oral isotretinoin for acne that is severe, that is causing scarring or psychosocial burden, or that has failed standard topical and oral therapy. The ladder is deliberate: creams first, tablets when creams have been given a fair run.

Adult acne is also common enough that it is rarely a sign something unusual is happening. A 2008 study in the Journal of the American Academy of Dermatology surveyed 1,013 adults aged 20 and over and found that 73.3% reported having had acne at some point, with women more likely than men to report it in every age group after the teenage years.

The trigger for escalating is usually lesion type rather than lesion count. Deep, tender nodules that last for weeks, lesions that leave a depression when they heal, and acne that returns within days of stopping a topical are the patterns that push clinicians toward a systemic drug. Flat pink or brown marks left after a spot has healed are a different problem with a different answer — those are covered in our guide to preventing post-inflammatory hyperpigmentation, and treating them with a systemic drug spends risk on something that was already fading.

What does isotretinoin do, and how long is a course?#

Isotretinoin is an oral retinoid, chemically 13-cis-retinoic acid, that shrinks sebaceous glands and sharply reduces how much sebum the skin produces. That one mechanism cascades into the others: less sebum means a less hospitable follicle for Cutibacterium acnes, less bacterial activity means less inflammation, and the drug also normalises the way cells shed inside the follicle. It is the only acne medication that acts on all of the main drivers at once, which is why it sits at the top of the ladder rather than beside the other options.

A conventional course runs at roughly 0.5 to 1.0 mg per kilogram of body weight each day, aiming at a cumulative total of 120 to 150 mg per kilogram, which for most adults works out to four to six months of daily capsules. That cumulative target is widely used but not settled science — a 2015 review in the International Journal of Dermatology described the evidence behind the 120–150 mg/kg threshold as equivocal and based on low-grade studies. Lower daily doses stretched over longer periods are also prescribed, trading a slower response for milder dryness.

Results do not arrive on a straight line. Many people see acne get worse for the first two to six weeks before it improves, clearing becomes obvious somewhere around the second or third month, and skin often keeps improving for months after the last capsule. Relapse is part of the picture too: in one published series of 1,453 patients, 22.4% went on to a second course. A course that ends with clear skin is a durable remission for most people rather than a guarantee that acne will never return.

What are isotretinoin's risks, and what does Korea require before prescribing?#

Isotretinoin's defining risk is teratogenicity: exposure during pregnancy carries a high risk of serious birth defects, and this is an absolute contraindication rather than a caution. South Korea's Ministry of Food and Drug Safety introduced a risk management program in June 2019 to address it. The program asks prescribers to educate patients on teratogenic risk, obtain written acknowledgment that the patient understands it, provide contraception information, arrange pregnancy testing before dispensing, and ensure the medication is dispensed within seven days of the prescription.

Whether those steps actually happen is a separate question, and the published answer is uncomfortable. A 2021 study in Obstetrics and Gynecology Science reviewed Korean isotretinoin exposure cases reported to a counselling centre between April 2019 and June 2020 and found that 84.7% had received information about teratogenicity, 39.8% had received contraception guidance, 15.3% had given written confirmation of understanding, and only 0.8% had a pregnancy test before treatment began. National prescribing volume rose over the same era, from about 0.39 million prescriptions in 2017 to 0.97 million in 2021. For anyone who could become pregnant, the practical reading is to ask for each safeguard explicitly rather than assume the clinic will raise it.

The everyday side effects are milder and close to universal. Dry, cracked lips affect almost everyone on a standard dose; dry eyes, a dry nose with occasional nosebleeds, dry skin, muscle aches, and increased sun sensitivity are all common. Blood tests for liver enzymes and blood lipids are standard because both can rise during a course. Mood is the most debated item: regulators require a warning about depressive symptoms, while the research on whether isotretinoin causes them remains inconsistent, and several analyses have found depressive symptoms improve as acne clears. That ambiguity argues for reporting any mood change to the prescriber promptly rather than for avoiding the drug or dismissing the concern.

Which oral options do clinics use besides isotretinoin?#

Two other families of oral acne medication are in routine use, and both are aimed at people whose acne is inflammatory but not severe enough to justify isotretinoin. Oral antibiotics in the tetracycline class reduce Cutibacterium acnes and dampen inflammation; the 2024 American Academy of Dermatology guidelines make a strong recommendation for oral doxycycline and conditional recommendations for minocycline and sarecycline. The same guidelines add two good practice statements that change how antibiotics should be used: limit systemic antibiotic exposure, and combine them with topical therapy rather than running them alone.

Hormonal treatment is the second family, and it applies to adult women. Combined oral contraceptive pills and spironolactone both carry conditional recommendations in the 2024 guidelines. Spironolactone blocks androgen receptors and reduces sebum production, and it is prescribed off-label for acne in most countries. The guidelines note that potassium monitoring is not needed in healthy patients, though it is worth considering for people with risk factors for high potassium such as older age, other medical conditions, or interacting medications. Combined oral contraceptives carry their own contraindications, including smoking above a certain age and a history of blood clots.

Sebum output is the thread connecting all three families, which is also why people often notice pore appearance changing during a course — an effect covered in our guide to what pore treatment in Korea actually does. Oral medication changes how much oil the skin makes; it does not resize a pore that has already stretched.

What should you ask a Korean clinic before starting oral acne medication?#

An oral acne course is a months-long relationship rather than a single appointment, and that is the difference that catches visitors out. A laser session ends when you leave the room; an isotretinoin course needs monthly review, repeat blood tests, dose adjustments, and refills, none of which travel well. Anyone considering starting a course while in Korea should settle the continuity question first: who supervises months two through six, and what happens to the plan when you fly home.

Continuity aside, the questions that separate a considered prescription from a transactional one are about assessment. A clinician who examines the acne, names the lesion type, explains why one family of drug fits it, and states what the monitoring schedule will be is describing a plan. Broader signals for judging a clinic are collected in our guide to choosing a dermatology clinic in Korea.

Bring an accurate list of everything you currently take, including supplements and any vitamin A products, and mention past acne treatments and how each one performed. Tetracycline-class antibiotics and isotretinoin both interact with other medications, and a prescriber working from an incomplete list is working blind.

✨ In short#

Oral acne medication in Korea is prescription-only, and the three families answer to different situations. Isotretinoin is for severe, scarring, or treatment-resistant acne and carries the strictest requirements, including the pregnancy prevention program Korea's regulator introduced in 2019. Oral antibiotics are for moderate inflammatory acne, and belong in a short course paired with a topical rather than run indefinitely. Hormonal options suit adult women whose acne follows a hormonal pattern. Across all three, the question that predicts a good outcome is who supervises the months after the prescription is written.